Similar Articles
1101 Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
1102 Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib
1103 Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis
1104 Contemporary role of liver biopsy in hepatocellular carcinoma
1105 Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
1106 Role of microRNAs in the main molecular pathways of hepatocellular carcinoma
1107 Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma
1108 Systematic review and meta-analysis on the association of tuberculosis in Crohn’s disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα)
1109 Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
1110 Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA